Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease

International Journal of Obesity

Volumn 39, Issue 8, 2015, Pages 1236-1240

  Chang, P F ^a,b   Lin, Y C ^a,b   Liu, K ^a   Yeh, S J ^a,b   Ni, Y H ^c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b ORIENTAL INSTITUTE OF TECHNOLOGY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GENOMIC DNA; GLUCOSE; HEME OXYGENASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HMOX1 PROTEIN, HUMAN; MICROSATELLITE DNA;

ADOLESCENT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIOCHEMICAL ANALYSIS; BODY MASS; CHILD; CHILDHOOD DISEASE; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; DINUCLEOTIDE REPEAT; ECHOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; LIVER EXAMINATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NONALCOHOLIC FATTY LIVER; PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; COMPLICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PEDIATRIC OBESITY; PROMOTER REGION; RISK FACTOR; TAIWAN;

ADOLESCENT; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; HUMANS; INSULIN RESISTANCE; MALE; MICROSATELLITE REPEATS; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PEDIATRIC OBESITY; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; TAIWAN;

EID: 84938741240     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.46     Document Type: Article

References (39)

1. Janssen I, Katzmarzyk PT, Boyce WF, Vereecken C, Mulvihill C, Roberts C et al. Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns. Obes Rev 2005; 6: 123-132
2. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419
3. Lin YC, Chang PF, Hu FC, Chang MH, Ni YH. Variants in the UGT1A1 gene and the risk of pediatric non-alcoholic fatty liver disease. Pediatrics 2009; 124: 1221-1227
4. Lin YC, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH. A common variant in the PNPLA3 gene is a risk factor of non-alcoholic fatty liver disease in Taiwanese obese children. J Pediatr 2011; 158: 740-744
5. Lin YC, Chang PF, Chang MH, Ni YH. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children. Am J Clin Nutr 2013; 97: 326-331
6. Lin YC, Chang PF, Chang MH, Ni YH. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. Am J Clin Nutr 2014; 99: 869-874
7. Ludwig J, McGill DB, Lindor KD. Nonalcoholic steatohepatitis. J Gastroenterol Hepatol 1997; 12: 398-403
8. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK et al. Non alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-1192
9. Kawakami T, Takahashi T, Shimizu H, Nakahira K, Takeuchi M, Katayama H et al. Highly liver-specific heme oxygenase-1 induction by interleukin-11 prevents carbon tetrachlorideinduced hepatotoxicity. Int J Mol Med 2006; 18: 537-546
10. Tsui TY, Lau CK, Wu X, Wang YQ, Farkas S et al. rAAV-mediated stable expression of heme oxygenase-1 in stellate cells: a new approach to attenuate liver fibrosis in rats. Hepatology 2005; 42: 335-342
11. Takahashi T, Shimizu H, Morimatsu H, Inoue K, Akagi R, Morita K et al. Heme oxygenase- 1a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev Med Chem 2007; 7: 745-753
12. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650
13. Ryter SW, Kim HP, Nakahira K, Zuckerbraun BS, Morse D, Choi AM. Protective functions of heme oxygenase-1 and carbon monoxide in the respiratory system. Antioxid Redox Signal 2007; 9: 2157-2173
14. Ryter SW, Morse D, Choi AM. Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. Am J Respir Cell Mol Biol 2007; 36: 175-182
15. Lavrovsky Y, Schwartzman MC, Levere RD, Kappas A, Abraham NG. Identification of binding sites for transcription factors NF-B and AP-2 in the promoter region of the human heme oxygenase-1 gene. Proc Natl Acad Sci USA 1994; 91: 5987-5991
16. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000; 66: 187-195
17. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 2002; 111: 1-8
18. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 2002; 22: 1680-1685
19. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35: 367-372
20. Chen W, Chang MH. New growth charts for Taiwanese children and adolescents based on World Health Organization standards and health-related physical fitness. Pediatr Neonatol 2010; 51: 69-79
21. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379
22. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes 2008; 32: 381-387
23. Fu JF, Shi HB, Liu LR, Jiang P, Liang L, Wang CL et al. Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children? World J Gastroenterol 2011; 17: 735-742
24. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004; 28: 1257-1263
25. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090
26. Naylor LH, Clark EM. d(TG)n.d(CA)n sequences upstream of the rat prolactin gene from Z-DNA and inhibit gene transcription. Nucleic Acids Res 1990; 18: 1595-1601
27. Hinds TD Jr, Sodhi K, Meadows C, Fedorova L, Puri N, Kim DH et al. Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity 2014; 22: 705-712
28. Farombi EO, Surh YJ. Heme-oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 2006; 39: 479-491
29. Camara NO, Soares MP. Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic Biol Med 2005; 38: 426-435
30. Neto JS, Nakao A, Kimizuka K, Romanosky AJ, Stolz DB, Uchiyama T et al. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol 2004; 287: F979-789
31. Lickteig AJ, Fisher CD, Augustine LM, Cherrington NJ. Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis. J Biochem Mol Toxicol 2007; 21: 216-220
32. Yu J, Chu ES, Wang R, Wang S, Wu CW, Wong VW et al. Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice. Gastroenterology 2010; 138: 694-704
33. Utzschneider KM, Kahn SE. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006; 91: 4753-4761
34. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850
35. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: Sites and mechanisms. Diabetologia 2005; 48: 634-642
36. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023-3028
37. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-1727
38. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: A multicenter retrospective study. J Pediatr 1995; 127: 700-704
39. Ueki K, Kondo T, Tseng YH, Kahn CR. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci USA 2004; 101: 10422-10427